Video

Don't Write Off Immunotherapy in Brain Cancer Just Yet

Author(s):

David Reardon, M.D.

Researchers should not give up hope in using immunotherapy to treat brain cancers.

Although negative results from trials evaluating immunotherapy and brain cancer were presented at the 2018 American Society of Clinical Oncology (ASCO) annual meeting, David Reardon, M.D., clinical director for the Center for Neuro-Oncology, Medical Oncology at the Dana-Farber Cancer Institute and associate professor of Medicine at Harvard Medical School, says that we shouldn’t write off the possibility of this treatment regimen just yet.

Brain cancers like glioblastoma (GBM) are notoriously difficult to treat, so it is going to take more research and hard work to determine how these agents can fit into the arsenal for treating GBM, he added.

Related Videos
Image of man with black hair.
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Image of woman with blonde hair.
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Related Content
Illustration of woman with blonde hair.
November 20th 2024

What Patients with Breast Cancer Need to Know About Lymphedema Risk

Alex Biese
CURE® spoke with a physical therapist specializing in oncology to find out more about this condition some patients with cancer are at risk for.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Image of a woman with short blonde hair, wearing a colorful striped shirt.
November 19th 2024

Why Clinical Trials Don’t Have to Be Patients’ ‘Last Line of Defense’

Alex Biese
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients with cancer to enroll.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Illustration of brain.
November 14th 2024

Optune Plus Temodar and Keytruda May Result in Brain Tumor Control

Ariana Pelosci
Patients with glioblastoma experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, researchers have reported.
Image of woman with black hair.
November 12th 2024

Managing Trodelvy’s Side Effects Through Dose Adjustment

Spencer Feldman
An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose adjustments.